Medical ganja’s slow journey irks foreign investor
Lack of unity between the different parties that need to be in congruence in order for Jamaica to be an international ganja-exporting force
Sunday, April 9, 2017
A foreign investor is expressing concern that Jamaica’s delay in establishing a medical ganja industry is providing other countries with the advantage to maximise from the opportunities to cement themselves in the export trade. Recently, Health Canada, issued export permits to a licensed Canadian firm for medical cannabis oils, which received purchase orders for distribution to both Australia and the Cayman Islands for pharmacy dispensing, triggering more concern that Jamaica is too slow in getting the industry up and running. Cayman Islands Governor Helen Kilpatrick approved a bill that amends the Misuse of Drugs Bill 2016, allowing cannabis oil to be imported and sold for medicinal purposes. (See also: NCDA again defends ganja study amid criticisms)
